8420302

Source:http://linkedlifedata.com/resource/pubmed/id/8420302

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:8420302	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:8420302	lifeskim:mentions	umls-concept:C0033325	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C0023473	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C1521970	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C1704632	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C0871261	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C2911692	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C1706817	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C0205390	lld:lifeskim
pubmed-article:8420302	lifeskim:mentions	umls-concept:C1518071	lld:lifeskim
pubmed-article:8420302	pubmed:issue	1	lld:pubmed
pubmed-article:8420302	pubmed:dateCreated	1993-2-5	lld:pubmed
pubmed-article:8420302	pubmed:abstractText	To determine the clinical and laboratory characteristics and outcomes of patients with chronic myelogenous leukemia (CML) in the lymphoid blastic phase.	lld:pubmed
pubmed-article:8420302	pubmed:language	eng	lld:pubmed
pubmed-article:8420302	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:8420302	pubmed:citationSubset	AIM	lld:pubmed
pubmed-article:8420302	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:8420302	pubmed:month	Jan	lld:pubmed
pubmed-article:8420302	pubmed:issn	0002-9343	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:PierceSS	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:EsteyEE	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:KeatingMM	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:O'BrienSS	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:TalpazMM	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:CorkAA	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:KantarjianH...	lld:pubmed
pubmed-article:8420302	pubmed:author	pubmed-author:DerderianP...	lld:pubmed
pubmed-article:8420302	pubmed:issnType	Print	lld:pubmed
pubmed-article:8420302	pubmed:volume	94	lld:pubmed
pubmed-article:8420302	pubmed:owner	NLM	lld:pubmed
pubmed-article:8420302	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:8420302	pubmed:pagination	69-74	lld:pubmed
pubmed-article:8420302	pubmed:dateRevised	2007-11-15	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:meshHeading	pubmed-meshheading:8420302-...	lld:pubmed
pubmed-article:8420302	pubmed:year	1993	lld:pubmed
pubmed-article:8420302	pubmed:articleTitle	Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.	lld:pubmed
pubmed-article:8420302	pubmed:affiliation	Department of Hematology, M.D. Anderson Cancer Center, Houston, Texas 77030.	lld:pubmed
pubmed-article:8420302	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:8420302	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed